These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6149575)

  • 1. Structure and activation of complement components C2 and factor B.
    Gagnon J
    Philos Trans R Soc Lond B Biol Sci; 1984 Sep; 306(1129):301-9. PubMed ID: 6149575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial sequence of human complement component factor B: novel type of serine protease.
    Christie DL; Gagnon J; Porter RR
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4923-7. PubMed ID: 6776529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human complement proteins D, C2, and B. Active site mapping with peptide thioester substrates.
    Kam CM; McRae BJ; Harper JW; Niemann MA; Volanakis JE; Powers JC
    J Biol Chem; 1987 Mar; 262(8):3444-51. PubMed ID: 3546307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The functional inhibition of activated C1 inhibitor in normal human serum causes spontaneous consumption of the complement components C2, C3, C4, and factor B.
    Gronski P; Bodenbender L; Kanzy EJ; Piepenbrock M; Seiler FR
    Immunobiology; 1986 Apr; 171(3):252-62. PubMed ID: 3011651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The proteolytic activation systems of complement.
    Reid KB; Porter RR
    Annu Rev Biochem; 1981; 50():433-64. PubMed ID: 7023363
    [No Abstract]   [Full Text] [Related]  

  • 6. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.
    Halili MA; Ruiz-Gómez G; Le GT; Abbenante G; Fairlie DP
    Biochemistry; 2009 Sep; 48(35):8466-72. PubMed ID: 19642650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MASP-2, the C3 convertase generating protease of the MBLectin complement activating pathway.
    Vorup-Jensen T; Jensenius JC; Thiel S
    Immunobiology; 1998 Aug; 199(2):348-57. PubMed ID: 9777418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
    Kozlov LV; Shibanova ED; Zinchenko AA
    Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino acid sequence of the Bb fragment from complement Factor B. Sequence of the major cyanogen bromide-cleavage peptide (CB-II) and completion of the sequence of the Bb fragment.
    Christie DL; Gagnon J
    Biochem J; 1983 Jan; 209(1):61-70. PubMed ID: 6342610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reaction of iodine and thiol-blocking reagents with human complement components C2 and factor B. Purification and N-terminal amino acid sequence of a peptide from C2a containing a free thiol group.
    Parkes C; Gagnon J; Kerr MA
    Biochem J; 1983 Jul; 213(1):201-9. PubMed ID: 6555044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C3 nephritic factor stabilization of the classic C3 convertase: a role for C2 in C3 nephritic factor activity.
    McLean RH; Nilson SH
    Proc Soc Exp Biol Med; 1979 Jul; 161(3):358-63. PubMed ID: 461464
    [No Abstract]   [Full Text] [Related]  

  • 12. The factor B and C2 genes.
    Campbell RD; Bentley DR; Morley BJ
    Philos Trans R Soc Lond B Biol Sci; 1984 Sep; 306(1129):367-78. PubMed ID: 6149579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural evidence that complement factor B constitutes a novel class of serine protease.
    Mole JE; Niemann MA
    J Biol Chem; 1980 Sep; 255(18):8472-6. PubMed ID: 6997298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of factor B of the complement system by kallikrein and its light chain.
    Hiemstra PS; Daha MR; Bouma BN
    Thromb Res; 1985 Jun; 38(5):491-503. PubMed ID: 3848216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural biology of the alternative pathway convertase.
    Xu Y; Narayana SV; Volanakis JE
    Immunol Rev; 2001 Apr; 180():123-35. PubMed ID: 11414354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A conserved element in the serine protease domain of complement factor B.
    Hourcade DE; Mitchell LM; Oglesby TJ
    J Biol Chem; 1998 Oct; 273(40):25996-6000. PubMed ID: 9748277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C2 by-pass: Cross-talk between the complement classical and alternative pathways.
    Laich A; Patel H; Zarantonello A; Sim RB; Inal JM
    Immunobiology; 2022 May; 227(3):152225. PubMed ID: 35567980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The structure of C2b, a fragment of complement component C2 produced during C3 convertase formation.
    Krishnan V; Xu Y; Macon K; Volanakis JE; Narayana SV
    Acta Crystallogr D Biol Crystallogr; 2009 Mar; 65(Pt 3):266-74. PubMed ID: 19237749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino acid sequence of the Bb fragment from human complement Factor B. Alignment of the cyanogen bromide-cleavage peptides.
    Gagnon J; Christie DL
    Biochem J; 1983 Jan; 209(1):51-60. PubMed ID: 6342609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The biochemistry of complement.
    Porter RR; Reid KB
    Nature; 1978 Oct; 275(5682):699-704. PubMed ID: 703835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.